Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cordero

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
Revista Espanola De Cardiologia (English Ed.)|August 12, 2020
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndromeJuan Sanchis, Jose María García Acuña, Sergio Raposeiras, et al.
Journal of Clinical Medicine|October 13, 2021
Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary SyndromePablo Díez-Villanueva, Jose María García-Acuña, Sergio Raposeiras-Roubin, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 13, 2025
Planning of lipid-lowering treatment in atherosclerotic vascular disease. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.NRosa Fernández-Olmo, Alberto Cordero, Armando Oterino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approachJose M de la Torre Hernandez, Ramon Lopez-Palop, Tamara Garcia Camarero, et al.
International Journal of Cardiology|August 24, 2023
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trialJuan Carlos Kaski, Nuria Lluch, Jose-Luis Lopez-Sendon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelinesJesús Martinón-Martínez, Belén Álvarez Álvarez, Teba González Ferrero, et al.
Journal of Cardiovascular Pharmacology|October 11, 2022
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness AnalysisJosé Seijas-Amigo, Alberto Cordero, Rosa F Olmo, et al.
European Journal of Clinical Investigation|August 30, 2022
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registryAlberto Cordero, Mª Rosa Fernández Olmo, Gustavo A Cortez Quiroga, et al.
Primary Care Diabetes|May 25, 2023
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phaseJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.
Journal of Cardiovascular Pharmacology|January 5, 2022
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL RegistryAlberto Cordero, M Rosa Fernández Del Olmo, Gustavo A Cortez Quiroga, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Revista Espanola De Cardiologia (English Ed.)|August 12, 2020
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndromeJuan Sanchis, Jose María García Acuña, Sergio Raposeiras, et al.
Journal of Clinical Medicine|October 13, 2021
Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary SyndromePablo Díez-Villanueva, Jose María García-Acuña, Sergio Raposeiras-Roubin, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|April 13, 2025
Planning of lipid-lowering treatment in atherosclerotic vascular disease. Consensus SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.NRosa Fernández-Olmo, Alberto Cordero, Armando Oterino, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 21, 2013
Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approachJose M de la Torre Hernandez, Ramon Lopez-Palop, Tamara Garcia Camarero, et al.
International Journal of Cardiology|August 24, 2023
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trialJuan Carlos Kaski, Nuria Lluch, Jose-Luis Lopez-Sendon, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelinesJesús Martinón-Martínez, Belén Álvarez Álvarez, Teba González Ferrero, et al.
Journal of Cardiovascular Pharmacology|October 11, 2022
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness AnalysisJosé Seijas-Amigo, Alberto Cordero, Rosa F Olmo, et al.
European Journal of Clinical Investigation|August 30, 2022
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registryAlberto Cordero, Mª Rosa Fernández Olmo, Gustavo A Cortez Quiroga, et al.
Primary Care Diabetes|May 25, 2023
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phaseJosé Seijas-Amigo, Ángel Salgado-Barreira, Rosana Castelo-Dominguez, et al.
Journal of Cardiovascular Pharmacology|January 5, 2022
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL RegistryAlberto Cordero, M Rosa Fernández Del Olmo, Gustavo A Cortez Quiroga, et al.
Pageof 20